Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Patient-Oriented Research

University of Toronto

$90,300.00

Assessing the physiological and behavioural effects of orally ingested cannabidiol (CBD) in older adults with dementia living at home

FY 2019-20

Summary
Background & Aim: The legalization of cannabis products has allowed access to cannabidiol (CBD), a non-psychoactive cannabinoid. According to our patient partners and the national organizations they represent, CBD oil is commonly being orally administered by caregivers to reduce the agitation and anxiety in older adults (OAs) with dementia - despite the many unknowns about CBD's health and safety effects. There is an urgent need for evidence to inform therapeutic practice. The aim of this pilot feasibility study is to explore the physiological, functional, and behavioural effects of orally ingested CBD by OAs with dementia living at home using an in-home sensor system. Design: We apply SPOR-PEF and Integrated Knowledge Translation principles. An Advisory Stakeholder Panel of knowledge users and experts will be formed. This pilot feasibility study targets OAs with dementia living at home with a caregiver. An in-home sensor system will collect continuous data with high sensitivity and objectivity to detect physiological data (e.g. heart rate, mobility data, motion or sedentary activity, sleep quality) and subtle changes in function and behaviour. Participants will be monitored for 2-weeks to establish control data, followed by a 6-week CBD oil period according to a protocol with gradually escalating doses. Caregivers will record observed changes in a digital diary and an RA will conduct bi-weekly visits. Caregiver interviews will be conducted to understand their perspectives about CBD. Statistical analysis will identify dose-related changes to outcomes, and the sample will be stratified to explore sex-related differences. Significance: This interdisciplinary project uses state-of-the-art technology to objectively assess physiological, functional, and behavioural changes related to CBD use. Results of this project will provide critical preliminary data and expand our understanding of the potential harms and benefits of CBD in OAs with dementia living at home.
Program
Catalyst Grant: Patient-Oriented Research
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
407203
Name
Chu CHARLENE H
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Catalyst Grant : Patient-Oriented Research
Projecttitle
Assessing the physiological and behavioural effects of orally ingested cannabidiol (CBD) in older adults with dementia living at home
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$90,300
Cihrequipment2
$0
Programname2
Catalyst Grant: Patient-Oriented Research
Keyworddelim
Agitation; Cannabidiol (Cbd) Oil; Cannabis; Caregiver; Dementia; Function; Home Care; Physiological Effects; Quality Of Life; Sensor Technology
Abstract
Background & Aim: The legalization of cannabis products has allowed access to cannabidiol (CBD), a non-psychoactive cannabinoid. According to our patient partners and the national organizations they represent, CBD oil is commonly being orally administered by caregivers to reduce the agitation and anxiety in older adults (OAs) with dementia - despite the many unknowns about CBD's health and safety effects. There is an urgent need for evidence to inform therapeutic practice. The aim of this pilot feasibility study is to explore the physiological, functional, and behavioural effects of orally ingested CBD by OAs with dementia living at home using an in-home sensor system. Design: We apply SPOR-PEF and Integrated Knowledge Translation principles. An Advisory Stakeholder Panel of knowledge users and experts will be formed. This pilot feasibility study targets OAs with dementia living at home with a caregiver. An in-home sensor system will collect continuous data with high sensitivity and objectivity to detect physiological data (e.g. heart rate, mobility data, motion or sedentary activity, sleep quality) and subtle changes in function and behaviour. Participants will be monitored for 2-weeks to establish control data, followed by a 6-week CBD oil period according to a protocol with gradually escalating doses. Caregivers will record observed changes in a digital diary and an RA will conduct bi-weekly visits. Caregiver interviews will be conducted to understand their perspectives about CBD. Statistical analysis will identify dose-related changes to outcomes, and the sample will be stratified to explore sex-related differences. Significance: This interdisciplinary project uses state-of-the-art technology to objectively assess physiological, functional, and behavioural changes related to CBD use. Results of this project will provide critical preliminary data and expand our understanding of the potential harms and benefits of CBD in OAs with dementia living at home.
Competitiondate
201909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chu, CHARLENE H; Beleno, Ron; Khan, Shehroz; Lanctôt, Krista L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $90,300~ $0~